Publication
Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor
dc.contributor.author | Marques, A | |
dc.contributor.author | Retroz-Marques, C | |
dc.contributor.author | Mota, S | |
dc.contributor.author | Cabral, R | |
dc.contributor.author | Campos, M | |
dc.date.accessioned | 2016-12-12T16:45:00Z | |
dc.date.available | 2016-12-12T16:45:00Z | |
dc.date.issued | 2014 | |
dc.description.abstract | Angiotensin-converting enzyme (ACE) inhibitors are the leading cause of a drug-induced angioedema. This occurrence is frequently underdiagnosed, but its relapse can be life-threatening. The authors' intention in reporting this clinical case is to sound a warning about reviewing attitudes and surveillance to try to improve patient perioperative safety. | pt_PT |
dc.identifier.citation | Case Rep Anesthesiol. 2014;2014:693191. | pt_PT |
dc.identifier.doi | 10.1155/2014/693191 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.4/2002 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.subject | Cuidados Pós-operatórios | pt_PT |
dc.subject | Inibidores da Enzima Conversora de Angiotensina | pt_PT |
dc.subject | Angioedema | pt_PT |
dc.title | Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 4 | pt_PT |
oaire.citation.startPage | 693191 | pt_PT |
oaire.citation.volume | 2014 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |